An Individual Urinary Proteome Analysis in Normal Human Beings to Define the Minimal Sample Number to Represent the Normal Urinary Proteome

Overview

Journal Proteome Sci

Publisher Biomed Central

Date 2012 Nov 23

PMID 23170922

Citations 15

Authors

Xuejiao Liu

Chen Shao

Lilong Wei

Jindan Duan

Shuzhen Wu

Xuewang Li

Mingxi Li

Wei Sun

Affiliations

Soon will be listed here.

Abstract

Unlabelled:

Background: The urinary proteome has been widely used for biomarker discovery. A urinary proteome database from normal humans can provide a background for discovery proteomics and candidate proteins/peptides for targeted proteomics. Therefore, it is necessary to define the minimum number of individuals required for sampling to represent the normal urinary proteome.

Methods: In this study, inter-individual and inter-gender variations of urinary proteome were taken into consideration to achieve a representative database. An individual analysis was performed on overnight urine samples from 20 normal volunteers (10 males and 10 females) by 1DLC/MS/MS. To obtain a representative result of each sample, a replicate 1DLCMS/MS analysis was performed. The minimal sample number was estimated by statistical analysis.

Results: For qualitative analysis, less than 5% of new proteins/peptides were identified in a male/female normal group by adding a new sample when the sample number exceeded nine. In addition, in a normal group, the percentage of newly identified proteins/peptides was less than 5% upon adding a new sample when the sample number reached 10. Furthermore, a statistical analysis indicated that urinary proteomes from normal males and females showed different patterns. For quantitative analysis, the variation of protein abundance was defined by spectrum count and western blotting methods. And then the minimal sample number for quantitative proteomic analysis was identified.

Conclusions: For qualitative analysis, when considering the inter-individual and inter-gender variations, the minimum sample number is 10 and requires a balanced number of males and females in order to obtain a representative normal human urinary proteome. For quantitative analysis, the minimal sample number is much greater than that for qualitative analysis and depends on the experimental methods used for quantification.

Citing Articles

Urinary Collectrin (TMEM27) as Novel Marker for Acute Kidney Injury.

Pajenda S, Wagner L, Gerges D, Herkner H, Tevdoradze T, Mechtler K Life (Basel). 2022; 12(9).

PMID: 36143426 PMC: 9503639. DOI: 10.3390/life12091391.

HBFP: a new repository for human body fluid proteome.

Shao D, Huang L, Wang Y, Cui X, Li Y, Wang Y Database (Oxford). 2021; 2021.

PMID: 34642750 PMC: 8516408. DOI: 10.1093/database/baab065.

Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer's Disease.

Watanabe Y, Hirao Y, Kasuga K, Tokutake T, Kitamura K, Niida S Dement Geriatr Cogn Dis Extra. 2020; 10(3):94-104.

PMID: 33082773 PMC: 7548924. DOI: 10.1159/000509561.

Human body-fluid proteome: quantitative profiling and computational prediction.

Huang L, Shao D, Wang Y, Cui X, Li Y, Chen Q Brief Bioinform. 2020; 22(1):315-333.

PMID: 32020158 PMC: 7820883. DOI: 10.1093/bib/bbz160.

Structural analysis of urinary light chains and proteomic analysis of hyaline tubular casts in light chain associated kidney disorders.

Reiter T, Knafl D, Agis H, Mechtler K, Wagner L, Winnicki W PeerJ. 2019; 7:e7819.

PMID: 31592189 PMC: 6778432. DOI: 10.7717/peerj.7819.

References

Decramer S, Wittke S, Mischak H, Zurbig P, Walden M, Bouissou F . Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med. 2006; 12(4):398-400. DOI: 10.1038/nm1384. View

Kentsis A, Monigatti F, Dorff K, Campagne F, Bachur R, Steen H . Urine proteomics for profiling of human disease using high accuracy mass spectrometry. Proteomics Clin Appl. 2010; 3(9):1052-1061. PMC: 2994589. DOI: 10.1002/prca.200900008. View

ORiordan E, Orlova T, Podust V, Chander P, Yanagi S, Nakazato M . Characterization of urinary peptide biomarkers of acute rejection in renal allografts. Am J Transplant. 2007; 7(4):930-40. DOI: 10.1111/j.1600-6143.2007.01733.x. View

Karp N, Lilley K . Investigating sample pooling strategies for DIGE experiments to address biological variability. Proteomics. 2008; 9(2):388-97. DOI: 10.1002/pmic.200800485. View

Eng J, McCormack A, Yates J . An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom. 2013; 5(11):976-89. DOI: 10.1016/1044-0305(94)80016-2. View

Diz A, Truebano M, Skibinski D . The consequences of sample pooling in proteomics: an empirical study. Electrophoresis. 2009; 30(17):2967-2975. DOI: 10.1002/elps.200900210. View

Weinkauf M, Hiddemann W, Dreyling M . Sample pooling in 2-D gel electrophoresis: a new approach to reduce nonspecific expression background. Electrophoresis. 2006; 27(22):4555-8. DOI: 10.1002/elps.200600207. View

Oh J, Pyo J, Jo E, Hwang S, Kang S, Jung J . Establishment of a near-standard two-dimensional human urine proteomic map. Proteomics. 2004; 4(11):3485-97. DOI: 10.1002/pmic.200401018. View

Zolg W . The proteomic search for diagnostic biomarkers: lost in translation?. Mol Cell Proteomics. 2006; 5(10):1720-6. DOI: 10.1074/mcp.R600001-MCP200. View

10.

Kentsis A . Challenges and opportunities for discovery of disease biomarkers using urine proteomics. Pediatr Int. 2010; 53(1):1-6. PMC: 4636200. DOI: 10.1111/j.1442-200X.2010.03253.x. View

11.

Nesvizhskii A, Aebersold R . Interpretation of shotgun proteomic data: the protein inference problem. Mol Cell Proteomics. 2005; 4(10):1419-40. DOI: 10.1074/mcp.R500012-MCP200. View

12.

Thongboonkerd V, Chutipongtanate S, Kanlaya R . Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: quantity, quality, and variability. J Proteome Res. 2006; 5(1):183-91. DOI: 10.1021/pr0502525. View

13.

Sun W, Gao S, Wang L, Chen Y, Wu S, Wang X . Microwave-assisted protein preparation and enzymatic digestion in proteomics. Mol Cell Proteomics. 2005; 5(4):769-76. DOI: 10.1074/mcp.T500022-MCP200. View

14.

Kaiser T, Kamal H, Rank A, Kolb H, Holler E, Ganser A . Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. Blood. 2004; 104(2):340-9. DOI: 10.1182/blood-2004-02-0518. View

15.

Molina L, Salvetat N, Ameur R, Peres S, Sommerer N, Jarraya F . Analysis of the variability of human normal urine by 2D-GE reveals a "public" and a "private" proteome. J Proteomics. 2011; 75(1):70-80. DOI: 10.1016/j.jprot.2011.06.031. View

16.

Rossing K, Mischak H, Dakna M, Zurbig P, Novak J, Julian B . Urinary proteomics in diabetes and CKD. J Am Soc Nephrol. 2008; 19(7):1283-90. PMC: 2440301. DOI: 10.1681/ASN.2007091025. View

17.

Cairns D, Barrett J, Billingham L, Stanley A, Xinarianos G, Field J . Sample size determination in clinical proteomic profiling experiments using mass spectrometry for class comparison. Proteomics. 2008; 9(1):74-86. DOI: 10.1002/pmic.200800417. View

18.

Brunner E, Ahrens C, Mohanty S, Baetschmann H, Loevenich S, Potthast F . A high-quality catalog of the Drosophila melanogaster proteome. Nat Biotechnol. 2007; 25(5):576-83. DOI: 10.1038/nbt1300. View

19.

Nagaraj N, Mann M . Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome. J Proteome Res. 2010; 10(2):637-45. DOI: 10.1021/pr100835s. View

20.

Sun W, Chen Y, Li F, Zhang L, Yang R, Zhang Z . Dynamic urinary proteomic analysis reveals stable proteins to be potential biomarkers. Proteomics Clin Appl. 2015; 3(3):370-82. DOI: 10.1002/prca.200800061. View